Screener
Nektar Therapeutics NKTR Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Nektar Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The source filing: Nektar Therapeutics’s 10-Q, filed May 8, 2026.
- Filed
- May 7, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-212596
| Line item | Three Months Ended March 31, | Three Months Ended March 31, | Three Months Ended March 31, |
|---|---|---|---|
| Non-cash interest expense on liabilities related to the sales of future royalties | (7,942) | (4,974) | |
| Interest income | 4,242 | 2,874 | |
| Other income (expense), net (including income of $2 and $321 for the three months ended March 31, 2026 and 2025, respectively, from a related party) | (336) | 266 | |
| Total non-operating income (expense), net | (4,036) | (1,834) | |
| Loss before provision for income taxes and equity method investment | (43,090) | (46,369) | |
| Provision for income taxes | 64 | 52 | |
| Loss before equity method investment | (43,154) | (46,421) | |
| Loss from equity method investment | (1,750) | (4,461) |
Item 1. Condensed Consolidated Financial Statements—Unaudited:
FAQ
- What is Nektar Therapeutics's other income (expense)?
- Nektar Therapeutics (NKTR) reported other income (expense) of -$4.04M in Q1 2026.
- How has Nektar Therapeutics's other income (expense) changed year-over-year?
- Nektar Therapeutics's other income (expense) decreased by 120.1% year-over-year, from -$1.83M to -$4.04M.
- What is the long-term trend for Nektar Therapeutics's other income (expense)?
- Over 3 years (2021 to 2025), Nektar Therapeutics's other income (expense) has grown at a -41.6% compound annual growth rate (CAGR), from -$77.18M to -$15.39M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.
Ask your AI about Nektar Therapeutics's other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude